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Microcystin-LR (MC-LR) is a potent cyanobacterial toxin responsible for animal and human 21 
poisonings worldwide. MC-LR is found in organisms throughout the foodweb, however there 22 
is conjecture regarding whether it biomagnifies. Few studies have investigated how MC-LR 23 
interacts with lipid membranes, a determinant of biomagnification potential. We tested whether 24 
1 µM MC-LR irreversibly associates with lipid bilayers or causes the creation of pore defects 25 
upon short and long-term exposure. Using tethered bilayer lipid membranes (tBLMs), we 26 
observed an increase in membrane conduction in tBLMs, representing an interaction of 27 
microcystin-LR with the lipid bilayer and a change in membrane packing properties. However, 28 
there were minimal changes in membrane capacitance upon short and long-term exposure, and 29 
MC-LR exhibited a rapid off-rate. Upon 24 h exposure to the toxin, no lipophilic multimeric 30 
complexes were detected capable of altering the toxin’s off-rate. There was no evidence of the 31 
creation of new pores. This study demonstrates that MC-LR does not irreversibly imbed itself 32 
into lipids membranes after short or long-term exposure and suggests MC-LR does not 33 











1. Introduction 43 
Cyanobacteria blooms are increasing in prevalence and severity, threatening both ecological 44 
and anthropogenic water requirements (Paerl & Fulton, 2006; Paerl et al., 2011; Drobac et al., 45 
2013). Many bloom-forming cyanobacteria produce toxic secondary metabolites and 46 
cyanotoxins that have been implicated in fish kills, deaths of waterbirds and other wildlife, 47 
livestock poisonings and human fatalities (Azevedo et al., 1996; Carmichael, 2001; Ibelings et 48 
al., 2005; White et al., 2005; Boopathi & Ki, 2014). Of all cyanotoxins, the hepatotoxic 49 
microcystins (MC) are the most widespread and problematic (Quiblier et al., 2013; Mowe et 50 
al., 2015). 51 
MCs are a structurally diverse group of cyclic heptapeptides, with 90+ isomers (Boopathi & 52 
Ki, 2014). They contain three D-amino acids (glutamic acid, erythro-β-methyl-aspartic acid 53 
and alanine), two variable L-amino acids, and two unique residues (Mdha and Adda) 54 
(Vesterkvist & Meriluoto, 2003). The toxicity of MC variants differs according to the 55 
combination of variable amino acids in the peptide ring (de Figueiredo et al., 2004; Schmidt et 56 
al., 2014). Microcystin-LR, a microcystin congener with a leucine and an arginine group, is 57 
among the most toxic and common (Carmichael, 1997; de Figueiredo et al., 2004). 58 
MC is frequently found in a variety of organisms, for example, aquatic plants (Mitrovic et al., 59 
2005), cladocerans (Ibelings et al., 2005), mussels (Barda et al., 2015), gastropods (Lance et 60 
al., 2008; Barda et al., 2015), fish (Ibelings et al., 2005; Papadimitriou et al., 2012; Vasconcelos 61 
et al., 2013) and mammals (Miller et al., 2010, van der Merwe et al., 2012). In higher 62 
organisms, MCs are actively and preferentially accumulated in the liver through organic anion 63 
transporting polypeptides (specifically, OATP1B1, OATP1B2, OATP1B3 and OATP1A2) 64 
involved in bile-acid transport in hepatocytes (Chorus & Bartram, 1999; Ito et al., 2008; 65 
McLellen & Manderville, 2017). They inhibit catalytic subunits of protein phosphatases-1 and 66 
-2A, cause acute hepatotoxicosis and may promote cancer (Bagu et al., 1997; Carmichael, 67 
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2001; de Figeuiredo et al., 2004). Small but notable concentrations of MC are found in various 68 
other tissues of rats and fish – for example the kidneys, heart, intestine, spleen, brain, gill, 69 
muscle, gonad and stomach (Ito et al., 2000; Lei et al., 2008; Wang et al., 2008). The 70 
identification of MCs in such varied organisms and tissues indicates a broad mechanism of 71 
toxicity and accumulation beyond the well-known bile-acid transporters in hepatocytes. Petrov 72 
et al. (1991) suggested that emplacement of MC’s Adda residue in lipid bilayers may occur 73 
due to its lipophilic and flexible tail that extends from the rigid cyclic backbone. This 74 
potentially creates pores and compromises cell membrane integrity.  75 
Lipophilic compounds, those that are soluble in lipids or oils, can impair the organisation of 76 
lipids in a membrane and disrupt the functioning of the cell (Vesterkvist & Meriluoto, 2003). 77 
Further, the capacity of a toxin to bioaccumulate and biomagnify can be influenced by 78 
lipophilicity as lipophilic chemicals tend to accumulate in the lipids of organisms where they 79 
are retained for extended periods and more readily transfer up trophic levels (Petersen & 80 
Kristensen, 1998; Ibelings et al., 2005; Amiard & Amiard-Triquet, 2015). The water-octanol 81 
partition coefficient (log Kow) of MC-LR is -1 at pH 7 (Ibelings et al., 2005), suggesting that 82 
the compound is relatively hydrophilic and may not strongly interact with lipids. However, 83 
microcystins are amphipathic, containing both lipophilic and hydrophilic regions (Figure 1) 84 
(Vesterkvist & Meriluoto, 2003). The lipophilic Adda residue and the variable amino acids in 85 
the peptide ring of MCs may impair lipid membrane structure or facilitate MC-LR 86 
accumulation within an organism (Orr & Jones, 1998; Zurawell et al., 2005; Schmidt et al., 87 




Figure 1. Chemical structure of microcystin-LR. (1) is D-alanine; (2) is the lipophilic 90 
variable amino acid L-Leucine; (3) is D-erythro-β-methylaspartic acid; (4) is the 91 
variable amino acid L-Arginine; (5) is the lipophilic residue Adda; (6) is D-glutamic 92 
acid; and (7) is N-methyldehydroalanine.  93 
Given that MC is regularly found in organisms across all trophic levels (Xie et al., 2005; Tokodi 94 
et al., 2018), there are also concerns regarding whether MC can biomagnify to affect upper 95 
trophic level organisms through the food web, such as fish, water birds, sea otters and humans 96 
(Xie et al., 2005; Miller et al., 2010).  Lipid membrane interactions are a common mechanism 97 
of assimilation, accumulation and biomagnification of toxins; however this has not yet been 98 
demonstrated with MC-LR (Ibelings et al., 2005; Kozlowsky-Suzuki et al., 2012; Schmidt et 99 
al., 2014). 100 
Despite the relatively low log Kow of MC-LR, the lipophilic Adda and variable amino acid 101 
regions of the compound, combined with suggestions of bioaccumulation and biomagnification 102 
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of MC-LR in the literature, may indicate some interaction between the cyanotoxin and lipid 103 
membranes. To determine whether MC-LR irreversibly associates with lipid bilayers, we 104 
investigated the interactions of the toxin with tethered bilayer lipid membranes (tBLMs), which 105 
provide a model for natural biological membranes (Cranfield et al., 2014; Cranfield et al., 106 
2015a) 107 
 108 
2. Materials and Methods 109 
2.1  Mass Spectroscopy 110 
Commercially available microcystin-LR was obtained and its purity tested prior to use using 111 
mass spectroscopy. Matrix Assisted Laser Desorption Ionisation MassSpectrometry (MALDI-112 
MS) using a 5800 MALDI TOF/TOF (AB Sciex, Framingham USA) in positive ion reflector 113 
mode was used. Its operation utilized a laser set to 4700, mass range set to 400-3000 Da with 114 
focal mass of 995 Da. 500 spectra were accumulated on a spot containing 1 ng of microcystin-115 
LR standard (Abraxis) co-crystallised with  α-Cyano-4-hydroxycinnamic acid (Sigma, USA) 116 
to assist in ionization. The concentration of microcystin used for tBLM experiments was 1 µM 117 
dissolved in phosphate buffered saline (PBS). This concentration was selected as it is on the 118 
upper end of those found in natural systems, so is representative of a toxic bloom scenario 119 
(Chorus, 2001). 120 
2.2 Tethered Bilayer Lipid Membranes (tBLMs) 121 
Lipid bilayers were anchored to a pure gold substrate using a combination of 10% tethering 122 
lipids and 90% spacer lipids as described previously (Figure 2A) (Cranfield et al., 2015b). In 123 
brief, pure 5N5 gold electrodes of 2.1 mm2 were pre-prepared with a coating of tethered benzyl-124 
disulfide (tetra-ethyleneglycol)n=2 C20-phytanyl tethers (DLP) and benzyl-disulfide-tetra-125 
ethyleneglycol-OH spacers (TEGOH) in the ratio of 1:9 (SDx Tethered Membranes Pty Ltd, 126 
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Australia). To these tethering chemistries were added 8 μL of a 3 mM solution of a mobile 127 
lipid phase dissolved in ethanol. After a 2 min incubation, the mobile phase lipids were washed 128 
three times with 3  400 μL of phosphate buffered saline (PBS). The lipids added consisted of 129 
70% zwitterionic C20 Diphytanyl-Glycero-Phosphatidylcholine lipid and 30% C20 130 
Diphytanyl-diglyceride-OH ether. To determine if the microcystin-LR might have an affinity 131 
for other membrane components, the membranes were supplemented with either 20% 132 
(mol/mol) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE, Avanti Lipids, 133 
USA) or 20% (mol/mol) cholesterol.  134 
2.3  AC electrical impedance spectroscopy (EIS) 135 
Phase and impedance measures were performed using an SDx tethaPod™ operated with SDx 136 
tethaQuick™ software (SDx Tethered Membranes Pty Ltd). Using a 50 mV peak-to-peak AC 137 
excitation at frequencies between 0.1 and 10,000 Hz with four steps per decade. Swept 138 
frequency EIS was employed to determine the change in membrane conduction (Gm) and 139 
changes in membrane capacitance (Cm). The data were fitted to an equivalent circuit 140 
comprising a Constant Phase Element (CPE) to represent the reservoir region (Krishna et al., 141 




Figure 2. A. Cartoon of a tethered lipid bilayer membrane (tBLM) with an 144 
intrinsic membrane pore defect. Benzyl-disulfide (tetra-ethyleneglycol)n=2 C20-145 
phytanyl tethers anchor a lipid bilayer to an underlying gold electrode. B. The 146 
equivalent circuit for modelling AC electrical impedance data. In this circuit, Rs 147 
represents the resistance of the electrolyte solution (PBS), Gm represents the 148 
conduction of the membrane, which is primarily determined by membrane pore 149 
defects, Cm is the membrane capacitance and CPE is a constant phase element 150 
used to model the tethering gold electrode and its surface chemistries. 151 
 152 
3. Results and Discussion 153 
The microcystin-LR used in the experiment was determined to be of high purity with minimal 154 
degradation by use of MALDI-MS, the highest abundant ions present in the sample being the 155 
expected mass of the intact microcystin (Figure 3). Microcystin-LR was tested on tBLMs 156 
containing Dyphytanyl PC lipids or mixtures of Diphytanyl lipids with 20% POPE or 20% 157 
cholesterol. POPE and cholesterol are membrane constituents necessary for the interactions of 158 
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numerous other toxins and peptides with lipid bilayers (Palmer, 2001; Henriques et al., 2011; 159 
Al Khamici et al., 2016; Cranfield et al., 2017). For each of the different membranes used there 160 
was a consistent increase in membrane conduction due to the presence of 1 µM microcystin-161 
LR (Figure 4A, C and E).  This response is consistent with a change in membrane packing 162 
brought about by the interaction of the microcystin-LR with the lipid bilayer. According to a 163 
membrane packing model, this alteration of the membrane packing arrangement causes an 164 
increase in the diameter of intrinsic toroidal pores within the membrane and is unlikely to be 165 
due to the formation of new pores (Cranfield et al., 2016; Cranfield et al., 2017; Kuppusamy et 166 
al., 2018). This data is supported by the fact that there is little change in membrane capacitance 167 
as a result of adding 1 µM microcystin-LR (Figure 4B, D and F). Membrane capacitance is 168 
directly influenced by membrane thickness and/or the water content at the bilayer. As a positive 169 
control, a pore-inducing cathelicidin peptide, LL-37, was later added (Turner et al., 1998; 170 
Nizalapur et al., 2016). This addition of LL-37 induced a definite change in membrane 171 
conduction and membrane capacitance. 172 
    173 
Figure 3. A, Mass-spectra of microcystin LR sample. The peak at 995.48 m/z 174 
corresponds with microcystin LR at 97% total ion intensity, 859.40 m/z corresponds to 175 
a fragmentation of the toxin releasing 136 Da corresponding to (2-176 
methoxyethyl)benzene. B, spectra zoomed to display the carbon isotope distribution of 177 





Following a PBS wash step microcystin-LR exhibited a rapid off-rate, which had little impact 180 
on the capacitance of the membranes. This indicates that despite its amphipathic properties, its 181 
lipophilicity is minimal as it can readily be removed by aqueous buffers. However, this does 182 
not preclude the possibility microcystin-LR might form oligomers that are more lipophilic in 183 
nature. To test this, we incubated tBLMs with microcystin-LR overnight before washing with 184 
PBS. Figure 5A-D are these membrane conduction and membrane capacitance traces for 185 
tBLMs exposed to 1 µM microcystin-LR in the presence of 20% POPE or 20% cholesterol 186 
lipids, respectively. It is evident that the tBLMs exhibit an increase in membrane conduction, 187 
with minimal changes in membrane capacitance. MC-LR is then readily washed out after the 188 
allotted time-period. This suggests that no lipophilic multimeric complexes are being formed 189 





Figure 4. A Membrane conduction changes over time as result of adding 1 µM 193 
microcystin-LR to tBLMs made of Diphytanyl PC with 30% diphytanyl-194 
diglyceride-OH lipids. A small increase in membrane conduction can be seen, 195 
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which is readily washed from the membrane subsequently by PBS buffer. LL-196 
37 peptide is added finally as a positive control. B, Capacitance measured over 197 
the same period indicating minimal changes to membrane thickness and/or water 198 
content as a result of the addition of microcystin-LR, which can be compared to 199 
the significant capacitance change due to LL-37 peptide. C, similar conduction 200 
responses, and D, capacitance responses, in membranes that include 20% 201 
mol/mol POPE lipids. E, similar conduction responses, and F, capacitance 202 






Figure 5. A, membrane conduction changes over a period of nearly 24 hours as 207 
result of adding 1 µM microcystin-LR to tBLMs containing 20% POPE lipids. 208 
A small increase in membrane conduction can be seen which is maintained a 209 
relatively steady level until the microcystin-LR is subsequently washed from the 210 
tBLM by PBS buffer. B, capacitance measures of the same period. C and D, are 211 
similar conduction and capacitance measures, respectively, in tBLMs containing 212 
20% cholesterol. All samples are n=3. 213 
The minimal effect of MC-LR on membrane capacitance after short and long-term exposure, 214 
and the rapid off-rate following the PBS wash, indicates that the toxin has minimal potential to 215 
imbed itself in or disrupt biological membranes. Therefore, the creation of pores, and/or the 216 
deterioration of membrane integrity, as was suggested by Petrov et al. (1991), is unlikely to be 217 
a contributing factor to MC-LR’s toxicity. Biomagnification of MC-LR is unlikely to occur 218 
due to the low residence time in lipids, and biodilution is likely to be the prevailing process 219 
(Ibelings, 2005; Kozlowsky-Suzuki, 2012). This is supported by Dyble et al. (2011) who found 220 
that orally administered MC-LR was eliminated rapidly (within 24 h) from the tissue of 221 
juvenile yellow perch.  222 
The present study showed some minor, temporary interaction of MC-LR with lipid membranes, 223 
most likely caused by the insertion of the lipophilic Adda residue. This interaction may explain 224 
the detection of the toxin in low quantities in a diverse range of species and tissue types (Ito et 225 
al., 2000; Wang et al., 2008; Lei et al., 2008). The introduction of cholesterol and POPE lipid 226 
to membranes indicated that the presence of lipid micro-domains has little influence on the 227 
toxin’s membrane insertion and retention time. Localised accumulation of MC-LR in 228 
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hepatocytes through the OATP transporters remains the likely route of exposure to toxic levels 229 
of MC-LR (Chorus & Bartram, 1999). 230 
While this study suggests that MC-LR does not biomagnify through the food web through lipid 231 
storage, this does not discount the possibility of other MC variants doing so. MC-LR is 232 
frequently cited as the most toxic and widespread of the microcystin family (Schmidt et al., 233 
2014; Rastogi et al., 2015), and many water quality guidelines often focus solely on MC-LR, 234 
such as those by the World Health Organisation (WHO) (Guidelines for drinking-water quality: 235 
fourth edition incorporating the first addendum, 2017). It should also be noted that the majority 236 
of cyanotoxin research focuses on MC-LR (de Figueiredo et al., 2004). Some microcystin 237 
isomers, such as MC-LF and MC-LW, are more lipophilic than the MC-LR variant (Vesterkvist 238 
et al., 2012) and Xie et al. (2004) noted that depuration of MC-RR in silver carp occurs far 239 
more slowly than MC-LR. These microcystins may represent a greater biomagnification 240 
potential than MC-LR. Further research should seek to clarify the differences in 241 
biomagnification potential between the microcystin congeners and establish water quality 242 
guidelines that incorporate other MC congeners that may threaten higher trophic level 243 
organisms.   244 
 245 
4. Conclusion 246 
Using tethered bilayer lipid membranes, we demonstrated that MC-LR does not irreversibly 247 
imbed itself into lipid membranes after short or long-term exposure. We observed an increase 248 
in membrane conduction in tBLMs, most likely caused by insertion of the lipophilic Adda 249 
residue, altering the overall membrane packing properties. However, there was minimal 250 
changes in membrane capacitance and MC-LR exhibited a rapid off-rate. When left to incubate 251 
with the membrane over 24 hours, the data suggests that no lipophilic multimeric complexes 252 
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were formed capable of altering the toxin’s off-rate, and no new pores were created. The 253 
temporary insertion of the Adda residue may explain the identification of the toxin in low 254 
quantities in a diverse range of species and tissue types (Ito et al., 2000; Wang et al., 2008; Lei 255 
et al., 2008), however MC-LR appears incapable of accumulating to high levels as a result of 256 
lipid insertion in these tissues. These findings indicate that biodilution, as opposed to 257 
biomagnification, is the prevailing process when MC-LR enters the foodweb.  258 
 259 
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